RCT Q4 2025 Earnings Significant EPS Miss Amidst Limited Revenue Disclosure C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution SSL Q1 2026 Earnings Modest EPS Beat Amidst Operational Discipline EVC Q1 2026 Earnings EPS of 013 Reported Stock Declines 11 on Limited Disclosures Two Harbors TWOD Q1 2026 Earnings EPS Surges Past Estimates as Interest Rate Environment Supports Mortgage REIT Performance HYNE Q1 2026 Earnings Net Loss of 002 Per Share as Stock Declines